⌘K

Home/Filings/4/A/0001209191-21-018770

4/A//SEC Filing

Clements Ian 4/A

Accession 0001209191-21-018770

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 7:42 PM ET

Size

4.9 KB

Accession

0001209191-21-018770

Insider Transaction Report

Form 4/AAmended

Period: 2020-12-23

Mirum Pharmaceuticals, Inc.MIRM

SVP Finance & Communications

Transactions

Purchase
Common Stock
2020-12-23$18.65/sh+1,592$29,691→ 7,871 total

Footnotes (1)

[F1]This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780080

Filing Metadata

Form type: 4/A
Filed: Mar 7, 7:00 PM ET
Accepted: Mar 8, 7:42 PM ET
Size: 4.9 KB

View on SEC.gov